Dermatology Case Reports

ISSN - 2684-124X


Treatment of Cutaneous Lymphoid Hyperplasia with Rituximab: A Case Report of 3 Patients

Marzieh Matin, Ali Asilian, Samaneh Mozafar Poor, Elaheh Haftbaradaran* and Amir Feily

Benign Cutaneous Lymphoid Hyperplasia (CLH) is a B-cell pseudolymphoma of an unknown origin. The face is the most affected site in CLH. This report presents the cases of 3 patients with CLH who were treated with rituximab.

It is a hypothesis that rituximab is useful for treating resistant-to-relapsing forms of CLH that do not respond to previous therapies but must be checked with appropriate designs research.